We are live on ! Find out more
VIVE

VIVEVE MED INC
VIVE

Delisted

VIVE was delisted on the 18th of January, 2023.

Back to rankings

18 hedge funds and large institutions have $665K invested in VIVEVE MED INC in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% less funds holding

Funds holding: 19 → 18 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

23% less capital invested

Capital invested by funds: $862K → $665K (-$197K)

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
E
Ergoteles
New York
+$16.6K
2
QPWM
Quadrant Private Wealth Management
Pennsylvania
+$10K
3
Renaissance Technologies
Renaissance Technologies
New York
+$1.75K
4
Citigroup
Citigroup
New York
+$1.23K
5
State Street
State Street
Massachusetts
+$662

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$40K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$35K
3
Citadel Advisors
Citadel Advisors
Florida
-$32K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$27.1K
5
Morgan Stanley
Morgan Stanley
New York
-$22.6K

VIVE Hedge Fund Activity: Q1 2022 in Review

18 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q1 2022, worth a combined $665K — down 23% from $862K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of VIVE and 4 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 3 added.

The largest buyer was Ergoteles, opening a new position worth an estimated $16.6K. The largest seller was Virtu Financial, exiting entirely with an estimated $40K sold.

  • 18 institutional investors held VIVEVE MED INC (VIVE) as of Q1 2022, down from 19 in Q4 2021.
  • Funds reported $665K of VIVEVE MED INC stock for Q1 2022, down 23% quarter-over-quarter.
  • 4 funds opened new VIVEVE MED INC positions in Q1 2022 and 5 closed out, a net change of -1 holder.
  • The largest VIVEVE MED INC buyer in Q1 2022 was Ergoteles, an estimated $16.6K added.
  • The largest VIVEVE MED INC seller in Q1 2022 was Virtu Financial, an estimated $40K sold.

Based on aggregated 13F filings for Q1 2022.